India to Antigua Pharmaceutical Export (2026) — $353.5K, 25 Suppliers | TransData Nexus

India to Antigua Pharmaceutical Export (2026) — $353.5K, 25 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Antigua

#	Formulation	Value	Share
1	Harmless Medicine for Human Consumption	$64.4K	18.2%
2	Harmless Medicine for Human Consumptionbatch Number. Tcwm7 Manufacturing Date.…	$15.5K	4.4%
3	Merimol 1gm IV Injection ( Paracetamol	$14.0K	4.0%
4	Isoniazid 300mg / Rifapentine 300mg Coat	$12.0K	3.4%
5	Flagapar - Jr Infusion - 1 X50mlnos	$12.0K	3.4%
6	Harmless Medicine for Human Consumptiontabs. Valsartan 160 MG Batch No. B8981l…	$11.0K	3.1%
7	Cort-s 100mg Injection (hydrocortisone	$10.0K	2.8%
8	Skicef 1.5gm Injection (cefuroxime 1.5gm	$8.1K	2.3%
9	Harmless Medicine for Human Consumptiontabs. Valsartan 80 MG Batch No. B9029w M…	$6.4K	1.8%
10	Contain Medicines Harmless Pharmaceutical Products Details As Perattached Expor…	$5.2K	1.5%
11	Batch No: Lbi2313, Brand: Cupid Lubricant, Generic- Cupid Lubricant Water Based…	$5.1K	1.4%
12	Harmless Medicine for Human Consumptiontabs. Valsartan 80 MG Batch No. B9029x M…	$3.7K	1.1%
13	Parasure 250 Suspension 100ml ( Met) Paracetamol Suspension BP 250mg/5ml B:273l…	$3.7K	1.0%
14	Veterinary Pharmaceuticals Wormcure (1 X 4's Per Box )(25000 Packs)	$3.5K	1.0%
15	Parasure 125 Suspension 100ml ( Met) Paracetamol Suspension BP 125mg/5ml B:273l…	$3.2K	0.9%

India exports 20+ pharmaceutical formulations to Antigua with a combined trade value of $353.5K. Key products include Isoniazid ($12K), Adalimumab ($3K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 912 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Antigua Trade Routes

1Isoniazid$12K

2Adalimumab$3K

These are the top pharmaceutical products exported from India to Antigua, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Antigua buyers, regulatory requirements, and logistics for that specific product corridor. Products include Isoniazid ($12K), Adalimumab ($3K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Antigua

1Vama Lifecare Private Limited

$105K

2Sunny Pharma

$69K

3Vea Impex (i) Private Limited

$34K

4Swiss Garnier Life Sciences

$32K

5Lotus International

Port Analysis — India to Antigua Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR69.6%

SAHAR AIR CARGO ACC (INBOM4)10.9%

DELHI AIR3.7%

Bombay Air Cargo9.9%

HYDERABAD AIR1.5%

Antigua Import Ports

ANTIGUA94.7%

SAN JOSE0.7%

ST JOHNS0.9%

GUATEMALA CITY0.1%

Trade Statistics

Total Value$353K

Shipments912

Indian Exporters25

Antigua Buyers30

Avg Shipment$388

Products685

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Antigua Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Antigua and Barbuda has experienced steady growth over the past decade. In 2024, India exported pharmaceutical products valued at approximately $410,000 to Antigua and Barbuda, marking a significant increase from previous years. This growth trajectory reflects the strengthening bilateral relations and the expanding reach of Indian pharmaceutical companies in the Caribbean region.

Key milestones in this trade relationship include the establishment of direct shipping routes and the participation of Indian pharmaceutical firms in regional trade fairs in the Caribbean. These initiatives have facilitated better market access and enhanced the visibility of Indian pharmaceutical products in Antigua and Barbuda. The consistent increase in export value underscores the growing demand for affordable and quality medicines from India in the Caribbean market.

2India's Market Position

In 2024, India's pharmaceutical exports to Antigua and Barbuda amounted to $410,000, contributing to a total of $5.24 million in exports from India to Antigua and Barbuda that year. This positions India as a significant supplier of pharmaceutical products to Antigua and Barbuda, highlighting the strategic importance of this trade corridor. The consistent growth in export value indicates a strengthening market position and the potential for further expansion in the Caribbean region.

Product Categories & Therapeutic Trends — India to Antigua

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

India's pharmaceutical exports to Antigua are predominantly in the cardiovascular and infectious disease therapeutic areas. The leading product, "HARMLESS MEDICINE FOR HUMAN CONSUMPTION," accounts for 18.2% of the total export value, indicating a significant demand for essential medications. Specific products like "MERIMOL 1GM IV INJECTION (PARACETAMOL)" and "SKICEF 1.5GM INJECTION (CEFUROXIME 1.5GM)" suggest a focus on treating infections and pain management. The presence of "VALSARTAN" tablets, a medication for hypertension, highlights the importance of managing cardiovascular conditions in Antigua. These therapeutic categories align with the healthcare needs of Antigua, where non-communicable diseases such as cardiovascular diseases and diabetes are prevalent. The government's commitment to providing free medications for chronic conditions underscores the demand for such pharmaceutical products.

2Emerging Opportunities

The global pharmaceutical industry is witnessing patent expirations, known as patent cliffs, presenting opportunities for Indian generic manufacturers to supply cost-effective alternatives. While specific patent cliffs in Antigua are not detailed, the country's reliance on imported pharmaceuticals suggests potential demand for generics. Additionally, the increasing prevalence of non-communicable diseases in Antigua, such as diabetes and cardiovascular diseases, creates a growing market for biosimilars. These biologic products offer cost-effective treatment options, aligning with Antigua's healthcare objectives to provide affordable care.

3Demand Drivers

Antigua's disease burden, characterized by a high prevalence of non-communicable diseases like diabetes and cardiovascular conditions, drives the demand for pharmaceutical imports. The aging population, projected to constitute 22.7% by 2060, further intensifies this need. In response, the government has increased healthcare spending per capita, reaching $1,085 in 2022, a 28.62% increase from 2021. This investment reflects a commitment to enhancing healthcare infrastructure and services, creating a conducive environment for pharmaceutical imports from India.

TransData Nexus Research · DGFT trade data analysisMar 2026

Supply Chain & Logistics — India to Antigua Pharma Shipments

Shipping routes, port infrastructure, cold chain compliance

1Shipping Routes & Transit

Pharmaceutical shipments from India to Antigua primarily utilize both sea and air transport, each with distinct advantages. Sea freight, though cost-effective, involves longer transit times, typically ranging from 30 to 40 days, depending on the specific ports and shipping lines. Air freight offers expedited delivery, with transit times of approximately 4 to 6 working days from major Indian airports to Antigua. For instance, shipments from Mumbai to Antigua via air can be completed within this timeframe, while those from other regions may require an additional 2 to 3 working days.

The Red Sea disruption, which began in early 2026, has significantly impacted global shipping routes, including those from India to Antigua. This disruption has led to longer transit times and increased costs for sea freight, as vessels are rerouted to avoid the affected area. Air freight has also experienced delays due to airspace restrictions and increased demand for alternative routes. Shippers have had to adapt by adjusting schedules and exploring alternative routes to mitigate the impact of the disruption.

2Port Infrastructure

In India, the primary export ports for pharmaceutical shipments are Sahar Air (69.6% of shipments), Sahar Air Cargo Acc (INBOM4) (10.9%), and Delhi Air (3.7%). These ports are equipped with facilities to handle pharmaceutical exports, including temperature-controlled storage and compliance with international shipping standards. In Antigua, the main import port is Antigua (94.7%), with smaller contributions from San Jose (0.7%) and St. John's (0.9%). The V.C. Bird International Airport in Antigua serves as the central hub for receiving international air freight, including pharmaceutical products. Both Antigua's port and airport facilities are equipped to handle pharmaceutical imports, ensuring compliance with international standards and regulations.

3Cold Chain & Compliance

Maintaining the integrity of temperature-sensitive pharmaceutical formulations during transit is critical. Good Distribution Practice (GDP) guidelines mandate that such products be stored and transported within specified temperature ranges to ensure efficacy and safety. For instance, many pharmaceuticals require storage between 2°C and 8°C. To comply with these standards, shipments must utilize temperature-controlled packaging, such as insulated containers with gel packs or dry ice, and be monitored using data loggers to record temperature fluctuations throughout the journey. Additionally, compliance with the World Health Organization's Good Manufacturing Practice (WHO-GMP) standards is essential for pharmaceutical products, ensuring that they are manufactured and distributed under conditions that meet international quality standards.

TransData Nexus Research · DGFT port data, shipping intelligenceMar 2026

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Antigua

Competing origins, India's edge, challenges and threats

1Competing Origins

Antigua and Barbuda's pharmaceutical market is supplied by various international and regional sources. In 2023, the United States was the leading exporter, providing approximately $3.36 million worth of pharmaceutical products, accounting for 29% of the market share. Germany followed with $1.29 million (11.2%), and Spain contributed $909,000 (7.84%). India's exports to Antigua and Barbuda in 2023 were valued at $449,000, representing 3.88% of the market share.

Other notable suppliers include the United Kingdom, France, and Panama, each holding smaller shares of the market. The European Union collectively contributes a significant portion, with Germany and France being prominent exporters. Regional suppliers such as Barbados and Panama also play roles in meeting Antigua and Barbuda's pharmaceutical needs. China's specific export data to Antigua and Barbuda is not readily available; however, China's global pharmaceutical export presence suggests a potential, albeit smaller, contribution to the market.

2India's Competitive Edge

India's pharmaceutical industry offers several competitive advantages in the Antigua and Barbuda market. The country's exports to Antigua and Barbuda in 2023 were valued at $449,000, representing 3.88% of the market share. India's cost competitiveness is a significant factor, enabling it to offer affordable pharmaceutical products. The industry is known for its adherence to WHO-GMP standards, ensuring high-quality manufacturing processes. Additionally, India's English-speaking workforce facilitates effective communication and collaboration. The country's broad portfolio of pharmaceutical products caters to diverse therapeutic areas, enhancing its appeal to international markets.

3Challenges & Threats

Despite its strengths, India's pharmaceutical exports to Antigua and Barbuda face several challenges. Regulatory tightening in both India and Antigua and Barbuda may impact the ease of market entry and compliance requirements. Competition from established suppliers like the United States and the European Union presents a threat, as these regions offer high-quality products and have established market presence. Perceptions regarding the quality of Indian pharmaceuticals, despite adherence to international standards, may influence purchasing decisions. Additionally, logistical challenges, including shipping times and costs, can affect India's competitiveness in the market.

TransData Nexus Research · Global trade databasesMar 2026

FAQ — India to Antigua Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Antigua?

India exported pharmaceuticals worth $353.5K to Antigua across 912 verified shipments.

Who are the top Indian pharmaceutical exporters to Antigua?

1. VAMA LIFECARE PRIVATE LIMITED — $105.1K. 2. SUNNY PHARMA — $69.4K. 3. VEA IMPEX (I) PRIVATE LIMITED — $34.4K. Total: 25 suppliers.

Which companies in Antigua import pharmaceuticals from India?

1. TO THE, — $64.4K. 2. CENTRAL MEDICAL STORES MINISTRY OF — $46.0K. 3. AS PER INVOICE — $40.8K. 30 buyers total.

What pharmaceutical products does India export most to Antigua?

1. Harmless Medicine for Human Consumption ($64.4K, 18.2%); 2. Harmless Medicine for Human Consumptionbatch Number. Tcwm7 Manufacturing Date.… ($15.5K, 4.4%); 3. Merimol 1gm IV Injection ( Paracetamol ($14.0K, 4.0%); 4. Isoniazid 300mg / Rifapentine 300mg Coat ($12.0K, 3.4%); 5. Flagapar - Jr Infusion - 1 X50mlnos ($12.0K, 3.4%)

Which ports handle pharmaceutical shipments from India to Antigua?

Export: SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4), DELHI AIR, Bombay Air Cargo, HYDERABAD AIR. Import: ANTIGUA, SAN JOSE, ST JOHNS, GUATEMALA CITY.

Why does Antigua import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $353.5K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Antigua?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Antigua pharmaceutical trade?

$388 per consignment across 912 shipments.

How many Indian pharmaceutical companies export to Antigua?

25 Indian companies. Largest: VAMA LIFECARE PRIVATE LIMITED with $105.1K.

How can I find verified Indian pharmaceutical suppliers for Antigua?

TransData Nexus covers 25 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Antigua identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 912 verified shipments from 25 Indian exporters to 30 Antigua buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

25 Exporters

30 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Antigua Pharmaceutical Export